HIMS
AZN icon

Hager Investment Management Services’s AstraZeneca AZN Stock Holding History

Hager Investment Management Services’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55K Hold
24
– – ﹤0.01% 294
2026
Q1 		$4.73K Sell
24
-1
-4% -$193 ﹤0.01% 271
2025
Q4 		$4.5K Buy
+25
New +$4.38K ﹤0.01% 260

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hager Investment Management Services's AZN Position: Q2 2026 in Review

Hager Investment Management Services held its AstraZeneca (AZN) position steady in Q2 2026 at 24 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #294.

Hager Investment Management Services first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.73K in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Hager Investment Management Services held 24 shares of AstraZeneca worth $4.55K as of Q2 2026.
  • Hager Investment Management Services left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Hager Investment Management Services's portfolio in Q2 2026, its #294 holding.
  • Hager Investment Management Services first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
  • Hager Investment Management Services's AstraZeneca position peaked at $4.73K in Q1 2026.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Hager Investment Management Services's 13F filing for Q2 2026, filed 20 Jul 2026.